Georgia Clinical & Translational Science Alliance

Research Resources
Research Resources
Translating new discoveries to advance health from bench to bedside to community
View Research Resources
Biostatistics, Epidemiology & Research Design
Clinical Research Centers
Collaboration & Team Science
Commercialization
Informatics
Integrating Special Populations
Recruitment
Regulatory Support & Ethics
Research Navigation
Education & Training
Education & Training
Training the next generation of clinical and translational investigators
View Education & Training
Bench2Market Series Talks
Capstone Design
Certificate Program in Translational Science
Clinical Research Professional Courses
eMPACT Career Advancement
Introduction to Clinical & Translational Research
K-Club
KL2
Master of Science in Clinical Research
TL1
Community
Community
Engaging the community in clinical research efforts
View Community
Community Engagement
Community Engagement Forum
Community Funding
Partners
Partner Database
ResearchMatch
Funding
Funding
Funding opportunities for developing the best approaches and methodologies to address complex translational and clinical research problems
View Funding
BizGrants
Community Funding
Pilot Grants
About
About
The institutions of the Georgia Clinical & Translational Science Alliance leverage their complementary strengths to accelerate clinical & translational education, research, & community engagement to impact health.
View About
What We Do
Leadership
News and Events
Evaluating Impact
Contact Us
Submit a Request
Submit a Request
Submit a Request
Request the types of assistance you need for your project
View Submit a Request
Submit a Request
Ask a Navigator

ACTSI Investigator Dr. Xiaodong Cheng in the News

January 23, 2013

Xiaodong Cheng, PhD, ACTSI investigator, biochemistry professor and Georgia Research Alliance Eminent Scholar, Emory University School of Medicine

Cell Therapy for Diabetes Neurovascular Complications: NIH $6.1M Grant Funds New Studies
October 4, 2011

Woodruff Health Sciences Update | Exploring cell therapy for diabetes complications
December 5, 2011

Dr. Cheng was selected as a 2012 Fellow of the American Association for the Advancement of Science (AAAS), an honor AAAS members bestow upon their peers. AAAS is the world's largest general scientific society and publisher of the journal Science. Cheng is a professor of biochemistry and a Georgia Research Alliance Eminent Scholar. He was cited by the AAAS for distinguished contributions to epigenetics by elucidating structural insights and enzymatic mechanisms of DNA and histonemodification enzymes.